| Latest Forum Topics / QT Vascular |
 Post Reply
|
|
Goldminer
|
|||||
|
sheerluck
Supreme |
01-Oct-2015 09:27
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Patent infringement lawsuit in their favour now. Mgmt expect to win case.
|
||||
| Useful To Me Not Useful To Me | |||||
|
cycy818
Master |
01-Oct-2015 09:13
|
||||
|
x 0
x 0 Alert Admin |
what d good news? notsostupid you huat liao..... |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
sheerluck
Supreme |
01-Oct-2015 09:10
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Chiong liao. So fast. |
||||
| Useful To Me Not Useful To Me | |||||
|
Composure
Senior |
30-Sep-2015 19:16
|
||||
|
x 0
x 0 Alert Admin |
convertible bonds
|
||||
| Useful To Me Not Useful To Me | |||||
|
sheerluck
Supreme |
30-Sep-2015 16:39
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Huh?!?!?! That 1.5mil buy queue shares yours?
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
blurtrader
Master |
30-Sep-2015 16:33
|
||||
|
x 0
x 0 Alert Admin |
i queued one de for fun
|
||||
| Useful To Me Not Useful To Me | |||||
|
sheerluck
Supreme |
30-Sep-2015 16:31
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Wah. QTV haven' t officially announced yet, buy queue already like liao. Likely to gap up liao once halt lifted...... 
|
||||
| Useful To Me Not Useful To Me | |||||
|
blurtrader
Master |
30-Sep-2015 16:00
|
||||
|
x 0
x 0 Alert Admin |
chiobu
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
tipusultan
Member |
30-Sep-2015 15:59
|
||||
|
x 0
x 0 Alert Admin |
Sorry for asking this question, what is CB Investor stand for?
|
||||
| Useful To Me Not Useful To Me | |||||
|
erhaier
Senior |
30-Sep-2015 15:36
|
||||
|
x 0
x 0 Alert Admin |
thanks for the post, tipusultan.! waiting to see mkt reaction after H... |
||||
| Useful To Me Not Useful To Me | |||||
|
sheerluck
Supreme |
30-Sep-2015 15:30
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Seems like they pull it through this time. One major hurdle down. Although unimpressive sale may still be an overcast but at least this verdict saves QTV from closing shop. Once QTV made the final annoucement on the case won and CB investors subscribe to the 2nd tranche, QTV should be quite ok to hoot liao.......see if shortists can make an even better entry price.... Not a buy/sell call. DYDD.
|
||||
| Useful To Me Not Useful To Me | |||||
|
tipusultan
Member |
30-Sep-2015 15:05
|
||||
|
x 0
x 0 Alert Admin |
i was unable edit the messege sorry for inconvience. Best regards. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
tipusultan
Member |
30-Sep-2015 15:03
|
||||
|
x 0
x 0 Alert Admin |
Yesterday Jurey at US court given the verdict in their favor. Do not forget TriReme is one of the QT group company. New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.New York (September 29, 2015, 10:40 PM ET) -- A California federal jury held that TriReme Medical did not infringe on a patent for a balloon stent claimed by AngioScore, holding that TriReme&rsquo s vascular stent did not infringe its competitor, attorneys for the parties told Law360 on Tuesday.
TriReme&rsquo s attorney David Caine of Arnold & Porter LLP said his client&rsquo s product, the Chocolate catheter, is the opposite of the device claimed in AngioScore&rsquo s U.S. Patent Number 7,691,119 and the jury&rsquo s verdict reflects that they agreed. &ldquo I would say that we were also very pleased that... To view the full article, register now.
|
||||
| Useful To Me Not Useful To Me | |||||
|
sheerluck
Supreme |
30-Sep-2015 14:18
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
How did you know?
|
||||
| Useful To Me Not Useful To Me | |||||
|
tipusultan
Member |
30-Sep-2015 13:57
|
||||
|
x 0
x 0 Alert Admin |
I think you are right, apparently they have won the case. |
||||
| Useful To Me Not Useful To Me | |||||
|
sheerluck
Supreme |
30-Sep-2015 11:16
Yells: "Work for your money first then let your money work for you" |
||||
|
x 0
x 0 Alert Admin |
Trading halted. Must be about the patent lawsuit. |
||||
| Useful To Me Not Useful To Me | |||||
|
erhaier
Senior |
30-Sep-2015 10:52
|
||||
|
x 0
x 0 Alert Admin |
no more forum interest in this counter? |
||||
| Useful To Me Not Useful To Me | |||||
|
erhaier
Senior |
25-Sep-2015 09:52
|
||||
|
x 0
x 0 Alert Admin |
when is the news for the law suit? sep right? |
||||
| Useful To Me Not Useful To Me | |||||
|
vivivava
Veteran |
21-Sep-2015 09:40
|
||||
|
x 0
x 0 Alert Admin |
good news? why wd cordis agree to the amendment ...reducing their stakes from sole distributor to just 88 health care providers? |
||||
| Useful To Me Not Useful To Me | |||||
|
Composure
Senior |
19-Sep-2015 19:06
|
||||
|
x 0
x 0 Alert Admin |
starting always rise on gd news only to be shorted down again need management to step in else the stock will never stabilise above 10c
|
||||
| Useful To Me Not Useful To Me | |||||